Insight

Alessandro Santin: This is a major ‘bench-to-bedside’ accomplishment for uterine cancer patients

Photo taken from medicine.yale.edu

Aug 2, 2024, 14:00

Alessandro Santin: This is a major ‘bench-to-bedside’ accomplishment for uterine cancer patients

Yale Cancer Center made the following post on X:

“Led by Dr. Alessandro Santin and researchers at Yale Cancer Center, the TROPiCS-03 phase II study for patients with advanced or recurrent endometrial cancer has advanced to a phase III trial. ‘This is a major ‘bench-to-bedside’ accomplishment for uterine cancer patients,’ said Dr. Santin.”

Read further.
Source: Yale Cancer Center/X

advanced endometrial cancer Alessandro Santin bench-to-bedside cancer cancer treatment advancement clinical trial progress Dr. Alessandro Santin endometrial cancer treatment OncoDaily Oncology oncology research phase II study Phase III trial recurrent endometrial cancer TROPiCS-03 study uterine cancer research Yale Cancer Center

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage